Literature DB >> 31676885

18F-fluciclovine PET or PSMA PET for prostate cancer imaging?

Baris Turkbey1, Peter L Choyke2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31676885     DOI： 10.1038/s41585-019-0255-6

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

Review 1.  Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective.

Authors:  Thomas S C Ng; Xin Gao; Keyan Salari; Dimitar V Zlatev; Pedram Heidari; Sophia C Kamran
Journal:  Front Oncol       Date:  2021-07-28       Impact factor: 6.244

Review 2.  Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers.

Authors:  Hiroshi Fukushima; Baris Turkbey; Peter A Pinto; Aki Furusawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancers (Basel)       Date:  2022-06-17       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.